1,735 results match your criteria: "Primary Children's Hospital.[Affiliation]"
Front Pediatr
September 2024
Division of Urology, Department of Surgery, University of Utah/Primary Children's Hospital, Salt Lake City, UT, United States.
Objectives: To investigate the clinical presentation and outcomes for a series of female pediatric patients with severe anterior deflection of the urinary stream (ADUS) who were managed via urethromeatoplasty.
Methods: This single institution retrospective cohort study used the institutional billing database to identify female patients ≤18 years who received a urethromeatoplasty (CPT 53450) from 2007 to 2022. Patients were included if a substantial anterior deflection of their urinary stream was the primary indication for surgery.
J Pediatr Orthop
February 2025
Department of Orthopaedics, University of Utah.
Background: Removal of the metaphyseal screw from tension band plate constructs after correction of angular deformity in patients treated with hemiepiphysiodesis has been suggested as an alternative to removing the plate and both screws. While this has the potential benefit of easier implant removal and reinsertion in the event of rebound, there is debate in the literature regarding the benefits and risks of leaving the epiphyseal screw and plate in place.
Methods: Patients treated with hemiepiphysiodesis at the distal femur and/or proximal tibia with tension band plates and screws who underwent subsequent removal of the metaphyseal screw after correction were included.
J Nutr
December 2024
Perinatal Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Am J Transplant
October 2024
Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH. Electronic address:
J Am Coll Cardiol
November 2024
Division of Pediatric Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Background: Studies evaluating the prevalence and impact of recurrent rejection (RR) in pediatric heart transplant (HT) are sparse.
Objectives: The purpose of this study was to describe prevalence and impact of RR on cardiac allograft vasculopathy (CAV) and graft loss after pediatric HT.
Methods: Data on HT from January 1, 2000, to June 30, 2020, in the Pediatric Heart Transplant Society database were included.
Pediatr Rev
October 2024
Division of Hospital Medicine, Department of Pediatrics, Seattle Children's Hospital, University of Washington, and Seattle Children's Research Institute, Center for Clinical and Translational Research, Seattle, WA.
JAMA Pediatr
November 2024
Department of Pediatrics, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina.
J Thromb Haemost
September 2024
Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
Background: Little information regarding the management of invasive procedures in people with hemophilia B (HB) after undergoing gene therapy is available. Here, we report the management of invasive procedures in people with severe or moderately severe HB who had previously been treated with etranacogene dezaparvovec in the phase 2b and phase 3 Health Outcomes with Padua Gene; Evaluation in Hemophilia B clinical trials (NCT03489291 and NCT03569891).
Objectives: The objective of this study was to describe the use of exogenous FIX, endogenous FIX activity prior to invasive procedures, and peri- and postoperative bleeds in participants who underwent invasive procedures after receiving etranacogene dezaparvovec gene therapy.
Blood Adv
November 2024
Division of Hematology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD.
Cartilage
September 2024
Cell Sheet Tissue Engineering Center, Department of Molecular Pharmaceutics, Health Sciences, The University of Utah, Utah, USA.
Purpose: This study aimed to establish a combined histological assessment system of neo-cartilage outcomes and to evaluate variations in an established rat defect model treated with human juvenile cartilage-derived chondrocyte (JCC) sheets fabricated from various donors.
Methods: JCCs were isolated from the polydactylous digits of eight patients. Passage 2 (P2) JCC sheets from all donors were transplanted into nude rat chondral defects for 4 weeks (27 nude rats in total).
Pediatr Cardiol
September 2024
Intermountain Primary Children's Hospital, Salt Lake City, UT, USA.
Child Abuse Rev
February 2024
Primary Children's Hospital, Center for Safe and Healthy Families, Salt Lake City, Utah, USA.
Transplant Cell Ther
December 2024
Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts.
JCO Oncol Pract
September 2024
Aflac Cancer and Blood Disorders Center, Emory University School of Medicine / Children's Healthcare of Atlanta, Atlanta, GA.
Purpose: Brentuximab vedotin (BV) incorporation into frontline chemotherapy regimens improved outcomes for classic Hodgkin lymphoma (cHL). The shared mechanism of action of BV and vinca alkaloids as microtubulin inhibitors increased the potential risk of chemotherapy-induced peripheral neuropathy (CIPN). Rates of CIPN and use of protocol-stipulated dose modifications of a microtubulin inhibitor were examined on the Children's Oncology Group AHOD1331 study, which compared BV, doxorubicin, vincristine (VCR), etoposide, prednisone, cyclophosphamide (BV-AVE-PC; BV arm) with bleomycin containing doxorubicin, bleomycin, vincristine, etoposide, prednisone, cyclophosphamide (ABVE-PC; standard arm) in patients with high-risk cHL ages 2-21 years.
View Article and Find Full Text PDFJ Natl Cancer Inst
September 2024
University of Utah, Salt Lake City, UT, USA.
J Pediatr Surg
August 2024
University of Utah, Division of Pediatric Surgery, Salt Lake City, UT, USA. Electronic address:
EBioMedicine
October 2024
Department of Biomedical Informatics, Harvard Medical School, 10 Shattuck Street, Boston, MA, 02115, USA; Computational Health Informatics Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA. Electronic address:
Background: Clinical trials and registry studies are essential for advancing research and developing novel treatments. However, these studies rely on manual entry of thousands of variables for each patient. Repurposing real-world data can significantly simplify the data collection, reduce transcription errors, and make the data entry process more efficient, consistent, and cost-effective.
View Article and Find Full Text PDFClin Immunol
November 2024
Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD, United States of America; Institute for Clinical and Translational Research, St. Petersburg, FL, United States of America; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States of America.
Clin Cancer Res
November 2024
Division of Solid Tumor and Clinical Genetics, Department of Medicine and Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
J Child Neurol
October 2024
Division of Pediatric Neurology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA.
To determine whether there is a correlation of genetic diagnosis/result with long-term seizure freedom in pediatric epilepsy patients. This was a prospective and retrospective cohort study of children with epilepsy referred for genetic testing at a single center. The primary outcomes were presence and type of genetic diagnosis (pathogenic, benign, or variant of uncertain significance) and patient epilepsy status (seizure free, treatment failure, uncertain).
View Article and Find Full Text PDFJAMA Netw Open
September 2024
Department of Pediatrics, University of Cincinnati School of Medicine, Heart Institute, Cincinnati Children's Hospital, Cincinnati, Ohio.
Importance: The Pediatric Cardiac Critical Care Consortium (PC4) cardiac arrest prevention (CAP) quality improvement (QI) project facilitated a decreased in-hospital cardiac arrest (IHCA) incidence rate across multiple hospitals. The sustainability of this outcome has not been determined.
Objective: To examine the IHCA incidence rate at participating hospitals after the QI project ended and discern which factors best aligned with sustained improvement.
J Pediatr Gastroenterol Nutr
November 2024
Intermountain Primary Children's Hospital, Salt Lake City, Utah, USA.
Unlabelled: Diagnostic delay remains a barrier to improving biliary atresia (BA) outcomes. We tested the implementation feasibility of a two stage BA newborn screening program in an integrated healthcare system.
Methods: Under a waiver of consent, we measured direct bilirubin (DB) levels in well newborns undergoing standard of care hyperbilirubinemia screening at four hospitals.
J Community Health
September 2024
Department of Family Medicine, University of Virginia, Charlottesville, VA, USA.
Refugees arriving to the U.S. experience a high burden of both communicable and non-communicable diseases.
View Article and Find Full Text PDFPediatr Nephrol
January 2025
Intermountain Primary Children's Hospital, Salt Lake City, UT, USA.
Background: A successful transition from pediatric to adult healthcare for adolescent and young adult kidney transplant recipients is essential for maintaining graft and overall health. Readiness for transition is multifactorial and can be challenging to assess. The purpose of this study is to describe the development of a scoring system for a transition readiness assessment for pediatric kidney transplant recipients and assess overall and domain-specific readiness for transition.
View Article and Find Full Text PDFLaryngoscope
January 2025
Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, UT, USA.
Objective: Fetal imaging often identifies signs of upper airway obstruction due to micrognathia that may require airway intervention at delivery. This study investigated the role of quantitative fetal imaging measurements in predicting the need for otolaryngology consultation and intervention within a multidisciplinary Fetal Center.
Methods: Data were retrospectively collected from expectant mothers attending a multidisciplinary Fetal Center from January 2017 to October 2023.